首页> 外国专利> UQCRH, THE MARKERS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA AND PREDICTING SURVIVAL PERIOD OF A HEPATOCELLULAR CARCINOMA PATIENT, A KIT AND PREDICTION FOR PREDICTING SURVIVAL PERIOD OF A HEPATOCELLULAR CARCINOMA PATIENT USING THE MARKER

UQCRH, THE MARKERS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA AND PREDICTING SURVIVAL PERIOD OF A HEPATOCELLULAR CARCINOMA PATIENT, A KIT AND PREDICTION FOR PREDICTING SURVIVAL PERIOD OF A HEPATOCELLULAR CARCINOMA PATIENT USING THE MARKER

机译:UQCRH,用于诊断肝细胞癌和预测肝细胞癌患者生存期的标记,用于预测肝细胞癌患者生存期的工具箱和预测

摘要

PURPOSE: A composition for detecting a marker for diagnosing liver cancer, containing an agent measuring UQCRH(ubiquinol-cytochrome c reductase hinge protein) expression level is provided to early diagnose liver cancer and to predict life time of a patient after surgery. CONSTITUTION: A composition for detecting a marker for diagnosing liver cancer contains an agent measuring UQCRG gene mRNA level or protein level. The agent for measuring mRNA level is a primer pair or probe which specifically binds to UQCRG gene. The agent for measuring protein level is an antibody for UQCRH protein. A kit for diagnosing liver cancer contains the composition.
机译:目的:提供一种用于检测诊断肝癌的标志物的组合物,其包含测量UQCRH(泛醇-细胞色素c还原酶铰链蛋白)表达水平的试剂,以早期诊断肝癌并预测患者术后的寿命。构成:用于检测诊断肝癌的标志物的组合物包含测量UQCRG基因mRNA水平或蛋白质水平的试剂。用于测量mRNA水平的试剂是与UQCRG基因特异性结合的引物对或探针。用于测量蛋白质水平的试剂是UQCRH蛋白的抗体。用于诊断肝癌的试剂盒包含该组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号